0001415889-22-006747.txt : 20220617
0001415889-22-006747.hdr.sgml : 20220617
20220617163118
ACCESSION NUMBER: 0001415889-22-006747
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220615
FILED AS OF DATE: 20220617
DATE AS OF CHANGE: 20220617
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Huber Martin H. Jr.
CENTRAL INDEX KEY: 0001653276
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40925
FILM NUMBER: 221024343
MAIL ADDRESS:
STREET 1: C/O TESARO, INC.
STREET 2: 1000 WINTER STREET, SUITE 3300
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Xilio Therapeutics, Inc.
CENTRAL INDEX KEY: 0001840233
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 851623397
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 828 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 617-833-1027
MAIL ADDRESS:
STREET 1: 828 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
4
1
form4-06172022_040644.xml
X0306
4
2022-06-15
0001840233
Xilio Therapeutics, Inc.
XLO
0001653276
Huber Martin H. Jr.
828 WINTER STREET
SUITE 300
WALTHAM
MA
02451
false
true
false
false
PRESIDENT AND HEAD OF R&D
Stock Option (right to buy)
2.28
2022-06-15
4
A
0
20000
0
A
2032-06-14
Common Stock
20000
20000
D
The option award was granted on June 15, 2022 and will vest in equal monthly installments until June 15, 2026, subject to the Reporting Person's continued service through the applicable vesting date.
/s/ Chris Frankenfield, Attorney-in-Fact
2022-06-17